INNOVADERM CRO IS NOW INDERO.

Episode 10: Dr. Jasmina Jankicevic – Gene Therapy Uncovered

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Joining us is Dr. Jasmina Jankicevic, the Chief Medical Officer of Innovaderm. Dr. Jankicevic is a globally recognized authority in the field of dermatology drug and medical device development. Her extensive experience encompasses all phases of clinical research […]

Episode 9: Jason Shuris – Why Choose a Niche CRO?

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Today, we are joined by a guest who carries a wealth of experience spanning 25 years in the healthcare and life science sectors. Jason Shuris, the Chief Business Officer at Innovaderm, has held senior leadership roles in specialized […]

Episode 6: Dr. Bissonnette – How to Manage Placebo Response Rate in Atopic Dermatitis

Episode Notes Resources: The Role of Skin Barrier Dysfunction in Atopic Dermatitis Understanding Tape Stripping and Its Use in Clinical Research Using Biomarkers in Clinical Research Art of Protocol Writing for Atopic Dematitis Today marks a unique occasion as we are joined by our chief executive officer and medical director at Innovaderm, a company he […]

Episode 3: Edith SimĂ©on—Estimands Unveiled

Episode Notes [email protected]: Use this email to let us know what you want to hear about. Estimands Unveiled Our expert today, with over two decades of industry experience, will guide us through the significance of estimands in the planification of clinical trials. We will be focusing on three key aspects: Purposes and requirements Cross-functional responsibility […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.